Search the Newsreel

Danaher Corp (DHR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Raised EPS Guidance

Danaher leads volatile earnings moves with $7.58 billion at stake

Danaher Corp. is set to lead significant earnings-related market volatility with a potential $7.58 billion market value swing, as options price a 5.30% move ahead of its Q2 2026 earnings report. Interactive Brokers Group shows the highest implied volatility on the watchlist at 6.20%, …

Danaher Could Swing $7.33 Billion in Value After Earnings

This article examines the implied stock movements for several companies reporting earnings on July 21, 2026, based on options market data. Danaher Corp. is highlighted for a potential 5.30% swing, equivalent to $7.58 billion in market value, due to its mega-cap status and investor …

Danaher Corp. stock underperforms Monday when compared to competitors

Shares of Danaher Corp. (DHR) fell 1.33% to $201.11 on Monday, marking its second consecutive day of losses. The underperformance occurred during a generally grim trading session where the S&P 500 Index dropped 0.19% and the Dow Jones Industrial Average declined 0.59%.

Danaher Q2 2026 earnings preview

This article provides a preview of Danaher's Q2 2026 earnings. It suggests that more detailed information regarding the company's financial performance will be available once the full earnings report is released.

Danaher earnings up next: Can bioprocessing recovery continue?

Danaher Corporation is set to report Q2 earnings, with investors keenly watching for sustained bioprocessing recovery and the integration progress of its $9.9 billion Masimo acquisition. Analysts anticipate modest year-over-year growth but a sequential decline in profitability, while maintain a bullish "Strong Buy" rating …

Maheshwari Logistics files balancing note for Q4FY26 results

Danaher (DHR) Q2 Earnings Report Preview: What To Look For

Danaher (DHR) Q2 Earnings Report Preview: What To Look For Diversified science and technology company Danaher (NYSE:DHR) will be reporting results this Tuesday before market hours. Here's what you need to know. Danaher missed analysts' revenue expectations last quarter, reporting revenues of $5.95 billion, …

Danaher stock remains supported by earnings and margins

Danaher Corporation's stock is currently priced at $196.74, underpinned by strong financial results from 2025, including $23.9 billion in revenue and an adjusted diluted EPS of $7.66. Despite a 5.8% decline in core revenue, the company maintained a robust 27.3% adjusted operating margin, highlighting …

Danaher Aktie: EPS erwartet bei 1,84 Dollar

Danaher (DHR) Is Expanding Diagnostics With A StatLab Medical Products Deal

Danaher, through its Leica Biosystems unit, is set to acquire StatLab Medical Products, enhancing its diagnostics and anatomical pathology offerings with more consumables and instruments. This strategic move aims to strengthen Danaher's recurring revenue streams and better position it within the global anatomical pathology …

Form 4 Danaher Corporation For: 16 July By Investing.com

This article reports on a Form 4 filing for Danaher Corporation (DHR) dated July 16, as published by Investing.com. It mentions DHR's stock performance, showing a 2.10% increase. The content provided is minimal, primarily serving as a placeholder for a financial filing announcement.

Danaher Corp (NYSE: DHR) VP details 60-share stock tax withholding

Danaher Corp's VP and Chief Accounting Officer, Christopher Bouda, reported a tax-withholding disposition of 60 shares of common stock at $200.79 per share to cover tax liabilities. After this transaction, Bouda directly holds 9,107 shares and indirectly holds 679.101 shares through a 401(k) plan. …

Danaher (NYSE: DHR) director exercises options, 3,298 shares acquired

Danaher director Elias A. Zerhouni exercised options to acquire 3,298 common shares at an exercise price of $71.88, with 1,181 shares subsequently used for tax withholding at $200.79 per share. Following these transactions, Zerhouni directly holds 46,484.282 shares and indirectly holds 7,500 shares through …

Danaher Gears Up to Post Q2 Earnings: Is a Beat in the Offing?

Danaher Corporation (DHR) is set to release its Q2 2026 earnings, with analysts projecting a revenue increase of 2.6% to $6.09 billion and earnings per share of $1.84, a 2.2% rise. The company has consistently beaten Zacks Consensus Estimates in the past, and its …

Countdown to Danaher (DHR) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Danaher (DHR) is projected to report Q2 earnings of $1.84 per share and revenues of $6.09 billion, representing year-over-year increases of 2.2% and 2.6% respectively. Analysts have made slight downward adjustments to the EPS estimate, which can influence investor actions. Beyond overall revenue and …

Leica Biosystems acquires StatLab to strengthen anatomic pathology and AI-enabled cancer diagnostics

Leica Biosystems, a subsidiary of Danaher, announced its acquisition of StatLab Medical Products from Linden Capital Partners and Audax Private Equity. This deal will integrate StatLab's 50-year histology workflow portfolio with Leica Biosystems' computational pathology platform, aiming to enhance laboratory standardization for AI-driven cancer …

Liquidity Mapping Around (DHR) Price Events

This article analyzes Danaher Corporation (NYSE: DHR) using AI models to provide trading strategies and multi-timeframe signal analysis. It indicates strong near and mid-term sentiment but a weak long-term outlook, highlighting a significant risk-reward short setup. The analysis includes specific entry, target, and stop-loss …

Danaher stock holds steady as diversified life sciences portfolio underpins long-term growth

Danaher Corp. (ISIN US2358511028) is highlighted as a global life sciences and diagnostics supplier, appealing to long-term investors due to its diversified portfolio and recurring revenue streams. The company's focus on essential laboratory and clinical workflows, alongside strategic acquisitions and continuous improvement, underpins its …

Danaher’s Leica Biosystems to Acquire StatLab

Danaher's Leica Biosystems is set to acquire StatLab, a privately-held manufacturer of anatomical pathology products. StatLab, with over 50 years of history, offers products for pre-analytical and analytical histology, complementing Leica Biosystems' focus on cancer diagnostics. The acquisition aims to advance cancer diagnostics, improve …

Danaher stock may move 4.9% on July 21 earnings report By Investing.com

Danaher Corp. (DHR) shares are expected to move 4.9% following its earnings report on July 21, based on options data. The stock has historically surpassed this options-implied movement in three of its last eight earnings announcements. Notably, on October 21, 2025, shares increased by …

Market re-rating will take time: 360 ONE Asset CIO Anup Maheshwari

There May Be Reason For Hope In Jahez International Company for Information Systems Technology's (TADAWUL:6017) Disappointing Earnings

Danaher Stock Forecast 2026: The Bioprocessing Equipment Cycle Has Started and Few Are Watching

Danaher Stock Moves Higher As Company Delivers Strong Q1 Earnings Report

Danaher Stock Is Down 20% in 2026. Here’s Why Analysts Still See a $239 Target

Is Maheshwari Logistics (NSE:MAHESHWARI) Using Too Much Debt?

Smallcaps still overvalued, midcaps lead earnings momentum: Nischal Maheshwari

Maheshwari Logistics (NSE:MAHESHWARI) Could Become A Multi-Bagger

Investors Don't See Light At End Of Jahez International Company for Information Systems Technology's (TADAWUL:6017) Tunnel And Push Stock Down 25%

Jahez International Company for Information Systems Technology's (TADAWUL:6017) stock price dropped 4.7% last week; retail investors would not be happy

Maheshwari Logistics consolidated net profit declines 9.45% in the September 2022 quarter

Maheshwari Logistics Ltd. Share Price Today | Maheshwari Logistics Live NSE/BSE